Pathology of renal xenograft rejection in pig to non-human primate transplantation

Clinical Transplantation

Volumn 20, Issue SUPPL. 15, 2006, Pages 46-52

  Shimizu, Akira ^a,b   Yamada, Kazuhiko ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Acute cellular xenograft rejection; Acute humoral xenograft rejection; Baboon; Chronic xenograft rejection; Endothelial cells; Hyperacute rejection; Pig; Xenotransplantation

Indexed keywords

ALPHA 1,3 GALACTOSYLTRANSFERASE; COMPLEMENT MEMBRANE ATTACK COMPLEX; FIBRIN; IMMUNOGLOBULIN;

ACUTE GRAFT REJECTION; ANTIBODY DETECTION; ARTICLE; BABOON; CELLULAR IMMUNITY; CHRONIC GRAFT REJECTION; CLINICAL ASSESSMENT TOOL; CLINICAL FEATURE; CLINICAL STUDY; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; EXPERIMENTAL MODEL; HISTOPATHOLOGY; HYPERACUTE GRAFT REJECTION; KIDNEY DONOR; KIDNEY GRAFT REJECTION; KIDNEY HEMORRHAGE; KIDNEY INTERSTITIUM; KIDNEY TRANSPLANTATION; MICROANGIOPATHY; MICROTHROMBUS; MINIPIG; NONHUMAN; PRIMATE; PRIORITY JOURNAL; RELIABILITY; T LYMPHOCYTE; THROMBOCYTE; XENOTRANSPLANTATION;

ACUTE DISEASE; ANIMALS; ANTIBODY FORMATION; CHRONIC DISEASE; GALACTOSYLTRANSFERASES; GRAFT REJECTION; IMMUNITY, CELLULAR; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; PAPIO; SWINE; SWINE, MINIATURE; TRANSPLANTATION, HETEROLOGOUS;

EID: 33746467974     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2006.00550.x     Document Type: Article

References (52)

1. Sachs DH, Sykes M, Robson SC, Cooper DK. Xenotransplantation. Adv Immunol 2001: 79: 129.
2. Cascalho M, Ogle BM, Platt JL. Xenotransplantation and the future of renal replacement. J Am Soc Nephrol 2004: 15: 1106.
3. Sachs DH. The pig as a potential xenograft donor. Vet Immunol Immunopathol 1994: 43: 185.
4. Cooper DK, Gollackner B, Sachs DH. Will the pig solve the transplantation backlog? Annu Rev Med 2002: 53: 133.
5. Bach FH, Robson SC, Winkler H et al. Barriers to xenotransplantation. Nat Med 1995: 1: 869.
6. Auchincloss H Jr, Sachs DH. Xenogeneic transplantation. Annu Rev Immunol 1998: 16: 433.
7. Platt JL, Lin SS. The future promises of xenotransplantation. Ann N Y Acad Sci 1998: 862: 5.
8. Sandrin MS, Mc Kenzie IF. Recent advances in xenotransplantation. Curr Opin Immunol 1999: 11: 527.
9. Logan JS. Prospects for xenotransplantation. Curr Opin Immunol 2000: 12: 563.
10. Samstein B, Platt JL. Physiologic and immunologic hurdles to xenotransplantation. J Am Soc Nephrol 2001: 12: 182.
11. Phelps CJ, Koike C, Vaught TD et al. Production of alpha 1,3-galactosyltransferase-deficient pigs. Science 2003: 299: 411.
12. Kolber-Simonds D, Lai L, Watt SR et al. Production of alpha-1,3-galactosyltransferase null pigs by means of nuclear transfer with fibroblasts bearing loss of heterozygosity mutations. Proc Natl Acad Sci U S A 2004: 101: 7335.
13. Yamada K, Yazawa K, Shimizu A et al. Marked prolongation of porcine renal xenograft survival in baboons through the use of alpha1,3-galactosyltransferase gene-knockout donors and the cotransplantation of vascularized thymic tissue. Nat Med 2005: 11: 32.
14. Kuwaki K, Tseng YL, Dor FJ et al. Heart transplantation in baboons using alpha1,3-galactosyltransferase gene-knockout pigs as donors: Initial experience. Nat Med 2005: 11: 29.
15. Platt JL. Mechanisms of tissue injury in hyperacute xenograft rejection. ASAIO J 1992: 38: 8.
16. Rose AG, Cooper DK. A histopathologic grading system of hyperacute (humoral, antibody-mediated) cardiac xenograft and allograft rejection. J Heart Lung Transplant 1996: 15: 804.
17. R ose AG. Histopathology of cardiac xenograft rejection. In: C ooper DKC, K emp E, P latt JL, W hite DJG, eds. Xenotransplantation, 2nd edn. Berlin, Heidelberg, New York: Springer, 1996: 255.
18. Larsen S, Starklint H. Histopathology of kidney xenograft rejection. In: Cooper DKC, Kemp E, Platt JL, White DJG, eds. Xenotransplantation, 2nd edn. Berlin, Heidelberg, New York: Springer, 1996: 228.
19. Aziz S, Suzuki K, Thorning D. Mechanism of discordant cardiac xenograft rejection - an alternative view based on ultrastructural observation. In: Cooper DKC, Kemp E, Platt JL, White DJG, eds. Xenotransplantation, 2nd edn. Berlin, Heidelberg, New York: Springer, 1996: 273.
20. Bustos M, Platt JL. The pathology of cardiac xenografts. J Card Surg 2001: 16: 357.
21. Schuurman HJ, Cheng J, Lam T. Pathology of xenograft rejection: A commentary. Xenotransplantation 2003: 10: 293.
22. Oriol R, Cooper DKC. Major carbohydrate xenotransplantation antigens. In: Cooper DKC, Kemp E, Platt JL, White DJG, eds. Xenotransplantation, 2nd edn. Berlin, Heidelberg, New York: Springer, 1996: 24.
23. Bach FH, Robson SC, Ferran C et al. Endothelial cell activation and thromboregulation during xenograft rejection. Immunol Rev 1994: 141: 5.
24. Lawson JH, Platt JL. Molecular barriers to xenotransplantation. Transplantation 1996: 62: 303.
25. Palmetshofer A, Galili U, Dalmasso AP, Robson SC, Bach FH. Alpha-galactosyl epitope-mediated activation of porcine aortic endothelial cells: Type I activation. Transplantation 1998: 65: 844.
26. Robson SC, Schulte am Esch J 2nd, Bach FH. Factors in xenograft rejection. Ann N Y Acad Sci 1999: 875: 261.
27. Sachs DH, Leight G, Cone J, Schwarz S, Stuart L, Rosenberg S. Transplantation in miniature swine. I. Fixation of the major histocompatibility complex. Transplantation 1976: 22: 559.
28. Pennington LR, Lunney JK, Sachs DH. Transplantation in miniature swine. VIII. Recombination within the major histocompatibility complex of miniature swine. Transplantation 1981: 31: 66.
29. Dor FJ, Tseng YL, Cheng J et al. α 1,3-Galactosyltransferase gene-knockout miniature swine produce natural cytotoxic anti-Gal antibodies. Transplantation 2004: 78: 15.
30. Shimizu A, Meehan SM, Kozlowski T et al. Acute humoral xenograft rejection: Destruction of the microvascular capillary endothelium in pig-to-nonhuman primate renal grafts. Lab Invest 2000: 80: 815.
31. Shimizu A, Colvin RB, Yamanaka N. Peritubular capillaries in renal allo- and xeno-graft rejection. Clin Transplantion 2000: 14 (Suppl. 3): 6.
32. Shimizu A, Colvin RB. Determining the histologic and Immunopathologic features of acute humoral xenograft rejection. Graft 2001: 4: 44. 44.
33. Shimizu A, Yamada K, Yamamoto S et al. Thrombotic microangiopathic glomerulopathy in human decay accelerating factor-transgenic swine-to-baboon kidney xenografts. J Am Soc Nephrol 2005: 16: 2732.
34. Hancock WW. Immunopathology of discordant xenograft rejection. In: Cooper DKC, Kemp E, Platt JL, White DJG, eds. Xenotransplantation, 2nd edn. Berlin, Heidelberg, New York: Springer, 1996: 303.
35. Palmetshofer A, Galili U, Dalmasso AP, Robson SC, Bach FH. Alpha-galactosyl epitope-mediated activation of porcine aortic endothelial cells: Type II activation. Transplantation 1998: 65: 971.
36. McCurry KR, Kooyman DL, Alvarado CG et al. Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury. Nat Med 1995: 1: 423.
37. Cozzi E, White DJ. The generation of transgenic pigs as potential organ donors for humans. Nat Med 1995: 1: 964.
38. Schmoeckel M, Bhatti FN, Zaidi A et al. Orthotopic heart transplantation in a transgenic pig-to-primate model. Transplantation 1998: 65: 1570.
39. Cozzi E, Bhatti F, Schmoeckel M et al. Long-term survival of nonhuman primates receiving life-supporting transgenic porcine kidney xenografts. Transplantation 2000: 70: 15.
40. Buhler L, Yamada K, Kitamura H et al. Pig kidney transplantation in baboons: Anti-Gal(alpha)1-3Gal IgM alone is associated with acute humoral xenograft rejection and disseminated intravascular coagulation. Transplantation 2001: 72: 1743.
41. Zhong R, Luo Y, Yang H et al. Improvement in human decay accelerating factor transgenic porcine kidney xenograft rejection with intravenous administration of gas914, a polymeric form of alphaGAL. Transplantation 2003: 75: 10.
42. Auchincloss HJ. Cell-mediated xenoresponses: Strong or weak? Clin Transplant 1994: 8: 155.
43. Yamada K, Seebach J, Der Simonian H, Sachs DH. Human anti-pig T-cell mediated cytotoxity. Xenotransplantation 1996: 3: 179.
44. Kuwaki K, Knosalla C, Dor FJ et al. Suppression of natural and elicited antibodies in pig-to-baboon heart transplantation using a human anti-human CD154 mAb-based regimen. Am J Transplant 2004: 4: 363.
45. Houser SL, Kuwaki K, Knosalla C et al. Thrombotic microangiopathy and graft arteriopathy in pig hearts following transplantation into baboons. Xenotransplantation 2004: 11: 416.
46. McGregor CG, Teotia SS, Byrne GW et al. Cardiac xenotransplantation: progress toward the clinic. Transplantation 2004: 78: 1569.
47. Barth RN, Yamamoto S, LaMattina JC et al. Xenogeneic thymokidney and thymic tissue transplantation in a pig-to-baboon model: I. Evidence for pig-specific T-cell unresponsiveness. Transplantation 2003: 75: 1615.
48. Alwayn IP, Basker M, Buhler L, Cooper DK. The problem of anti-pig antibodies in pig-to-primate xenografting: Current and novel methods of depletion and/or suppression of production of anti-pig antibodies. Xenotransplantation 1999: 6: 157.
49. Lambrigts D, Sachs DH, Cooper DK. Discordant organ xenotransplantation in primates: World experience and current status. Transplantation 1998: 66: 547.
50. Kozlowski T, Shimizu A, Lambrigts D et al. Porcine kidney and heart transplantation in baboons undergoing a tolerance induction regimen and antibody adsorption. Transplantation 1999: 67: 18.
51. Sachs DH, Sablinski T. Tolerance across discordant xenogeneic barriers. Xenotransplantation 1995: 2: 234.
52. Lechler RI, Sykes M, Thomson AW, Turka LA. Organ transplantation: How much of the promise has been realized? Nat Med 2005: 11: 605.